Experience of Yttrium-90 radioembolization in patients with hepatocellular carcinoma

Experience of Yttrium-90 radioembolization in patients with hepatocellular carcinoma

Bibliographic Details
Main Authors:	B. Zapote Hernández, S. Amezquita Pérez, J.M. Torres Montoya, I. Verduzco Flores, E. Santiago González, V. Fonseca Morales, A. Gutiérrez Atemis, C. Pantaleón Martínez, N.C. Fernández Martínez, M.R. Herrero Maceda, J.G. Gándara Calderón, E. Cerda Reyes
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Series:	Annals of Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268120301289

Similar Items

Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma
by: Yu CY, et al.
Published: (2023-01-01)

Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer
by: Raval eMihir, et al.
Published: (2014-07-01)

Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases
by: Ron C. Gaba, et al.
Published: (2012-08-01)

Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer
by: Alexander C. Bunck, et al.
Published: (2017-07-01)

Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer
by: Yasaman Anbari, et al.
Published: (2023-11-01)

Evaluation of the ALBI, MELD, MELD-Na, MELD 3.0 score in patients with hepatocellular carcinoma treated with Yttrium-90 (90y)
by: Stefanny Cornejo-Hernandez, et al.
Published: (2024-02-01)

Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases
by: Ahmet Peker, et al.
Published: (2015-01-01)

Segmental Yttrium-90 Radioembolization as an Initial Treatment for Solitary Unresectable HCC
by: Natalie J. Rothenberger, et al.
Published: (2022-07-01)

Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
by: S. Peter Kim, et al.
Published: (2021-10-01)

Modeling the Synergistic Impact of Yttrium 90 Radioembolization and Immune Checkpoint Inhibitors on Hepatocellular Carcinoma
by: Minah Kang, et al.
Published: (2024-01-01)

Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer
by: Luciana Puleo, et al.
Published: (2023-01-01)

Radiation pneumonitis following Yttrium-90 radioembolization: A Korean multicenter study
by: Hyo-Cheol Kim, et al.
Published: (2023-01-01)

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients
by: Teyateeti A, et al.
Published: (2020-09-01)

A new model to estimate prognosis in patients with hepatocellular carcinoma after Yttrium-90 radioembolization.
by: Zhihong Weng, et al.
Published: (2013-01-01)

Intrahepatic flow diversion prior to segmental Yttrium-90 radioembolization for challenging tumor vasculature
by: Lindsay B. Young, et al.
Published: (2022-05-01)

Case Report of Cirrhosis following Yttrium-90 Radioembolization for Pancreatic Neuroendocrine Liver Metastases
by: Jonathan M. Loree, et al.
Published: (2016-01-01)

Cholecystitis after yttrium-90 resin microsphere radioembolization treatment: Clinical and pathologic findings
by: Sagun Parakh, et al.
Published: (2016-07-01)

Trans-arterial 90yttrium radioembolization for patients with unresectable tumors originating from the biliary tree
by: Joost W. Wijlemans, et al.
Published: (2011-07-01)

Prediction of hepatocellular carcinoma response to 90Yttrium radioembolization using volumetric ADC histogram quantification: preliminary results
by: Sonja Gordic, et al.
Published: (2019-05-01)

A systematic review on the safety and effectiveness of yttrium-90 radioembolization for hepatocellular carcinoma with portal vein tumor thrombosis
by: Zhongzhi Jia, et al.
Published: (2016-01-01)

Clinical Outcomes of Patients With Unresectable Primary Liver Cancer Treated With Yttrium-90 Radioembolization With an Escalated Dose
by: Re-I Chin, MD, MSCI, et al.
Published: (2022-07-01)

Transarterial Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma Patients: Outcome Assessment Applying a Prognostic Score
by: Imke Schatka, et al.
Published: (2022-10-01)

Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model
by: E. Courtney Henry, et al.
Published: (2022-03-01)

Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular Carcinoma
by: Alexander Villalobos, et al.
Published: (2023-11-01)

Effect of Yttrium-90 transarterial radioembolization in patients with non-surgical hepatocellular carcinoma: A systematic review and meta-analysis.
by: Simon Lemieux, et al.
Published: (2021-01-01)

Non-target activity detection by post-radioembolization yttrium-90 PET/CT: Image assessment technique and case examples
by: Yung Hsiang eKao, et al.
Published: (2014-02-01)

Economic evaluations of radioembolization with yttrium-90 microspheres in liver metastases of colorectal cancer: a systematic review
by: JC Alonso, et al.
Published: (2023-05-01)

Prediction of survival according to kinetic changes of cytokines and hepatitis status following radioembolization with yttrium-90 microspheres
by: Chien-An Liu, et al.
Published: (2021-04-01)

Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival.
by: Francesco Somma, et al.
Published: (2019-01-01)

Correction: Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model
by: E. Courtney Henry, et al.
Published: (2023-11-01)

Portal hypertension increases the risk of hepatic decompensation after 90Yttrium radioembolization in patients with hepatocellular carcinoma: a cohort study
by: Laura Carrión, et al.
Published: (2023-10-01)

Autoradiography and biopsy measurements of a resected hepatocellular carcinoma treated with 90 yttrium radioembolization demonstrate large absorbed dose heterogeneities
by: Jens Hemmingsson, MS, et al.
Published: (2018-07-01)

Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic review and meta-analysis
by: Yi Yang, et al.
Published: (2018-09-01)

Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience
by: Daniel Aliseda, et al.
Published: (2023-01-01)

Yttrium-90 Radioembolization of Metastatic Adrenocortical Carcinoma to the Liver following Systemic Chemotherapy and Surgical Resection of the Primary Lesion
by: Nicholas Pigg, et al.
Published: (2020-02-01)

Prospective longitudinal quality of life and survival outcomes in patients with advanced infiltrative hepatocellular carcinoma and portal vein thrombosis treated with Yttrium-90 radioembolization
by: Minzhi Xing, et al.
Published: (2018-01-01)

Comparison of Safety and Efficacy of Yttrium-90 Radioembolization for Nonalcoholic Fatty Liver Disease-Associated and Hepatitis B Virus-Associated Hepatocellular Carcinoma
by: Lei Liang, et al.
Published: (2020-03-01)

Prevalence of spontaneous bacterial peritonitis in patients with hepatic cirrhosis in the military central hospital
by: E. Perez-Méndez, et al.
Published: (2020-09-01)

Review of outcomes of combination therapy using yttrium 90 radioembolization and sorafenib/nivolumab for HCC with hepatic vein or IVC invasion
by: Shiqi Chung, et al.
Published: (2023-01-01)

Yttrium-90 radioembolization in desmoplastic small round cell tumor with recurrent hepatic metastasis following hyperthermic intraperitoneal chemotherapy
by: Harkanwar Gill, MD, et al.
Published: (2021-06-01)